USANA Health Sciences, Inc.
|
|
April 26, 2022
|
|
Q1 2022 Management Commentary
|
●
|
First quarter net sales were $273 million as compared with $308 million during the first quarter of the prior year.
|
●
|
First quarter diluted EPS totaled $1.15 versus $1.45 during the first quarter of 2021.
|
●
|
Company revises fiscal 2022 net sales and diluted EPS outlook to $1.1 billion to $1.2 billion and $5.00 to $5.70, respectively.
|
Consolidated Results
|
||
Net Sales
|
$272.9 million
|
● -11% vs. prior-year quarter
● -10% constant currency vs. prior-year quarter
● +2% constant currency sequentially
● -$2.8 million YOY FX impact, or -1%
|
Diluted EPS
|
$1.15
|
● -21% vs. prior-year quarter
● +12% sequentially
● Diluted shares of 19.5 million, -8% vs. prior-year quarter
|
Active Customers
|
552,000
|
● -11% vs. prior-year quarter
|
Asia Pacific Region
|
||
Net Sales
|
$218.4 million
|
● -13% vs. prior-year quarter
● -12% constant currency vs. prior-year quarter
● +3% constant currency sequentially
● 80% of consolidated net sales
|
Active Customers
|
422,000
|
● -11% vs. prior-year quarter
● -1% sequentially
|
Asia Pacific Sub-Regions
|
||
Greater China
|
||
Net Sales
|
$133.7 million
|
● -10% vs. prior-year
quarter
● Constant currency net sales: -12%
|
Active Customers
|
255,000
|
● -8% vs. prior-year quarter
● Flat sequentially
|
North Asia
|
||
Net Sales
|
$29.9 million
|
● -1% vs. prior-year quarter
● Constant currency net sales: +7%
|
Active Customers
|
57,000
|
● -3% vs. prior-year quarter
● -2% sequentially
|
Southeast Asia Pacific
|
||
Net Sales
|
$54.7 million
|
● -24% vs. prior-year quarter
● Constant currency net sales: -21%
|
Active Customers
|
110,000
|
● -20% vs. prior-year quarter
● -4% sequentially
|
Americas and Europe Region
|
||
Net Sales
|
$54.4 million
|
● -4% vs. prior-year quarter
● -3% constant currency vs. prior-year quarter
● -1% constant currency sequentially
● 20% of consolidated net sales
|
Active Customers
|
130,000
|
● -10% vs. prior-year quarter
● -2 % sequentially
|
Fiscal Year 2022 Outlook
|
||
Revised Range
|
Previous Range
|
|
Consolidated Net Sales
|
$1.100- $1.200 billion
|
$1.125 - $1.225 billion
|
Diluted EPS
|
$5.00 - $5.70
|
$5.25 - $6.00
|
●
|
An unfavorable currency exchange rate impact on net sales of approximately $16 million (previously $16 million);
|
●
|
An estimated operating margin between 13.0% and 13.6% (previously 13.5% and 14.1%);
|
●
|
An annual effective tax rate of 32.5% (previously 32.5%); and
|
●
|
An annualized diluted share count of 19.3 million (previously 19.6 million).
|
Investor contact:
|
Patrique Richards
|
Investor Relations
|
|
(801) 954-7823
|
|
investor.relations@usanainc.com
|
|
Media contact:
|
Dan Macuga
|
Public Relations
|
|
801-954-7280
|